Carson Wealth (CWM LLC)
HELP

Carson Wealth (CWM LLC)’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23
Closed – – 5415
2025
Q3 		$0 Hold
23
– – ﹤0.01% 5317
2025
Q2 		$0 Hold
23
– – ﹤0.01% 5145
2025
Q1 		$0 Hold
23
– – ﹤0.01% 5080
2024
Q4 		$0 Hold
23
– – ﹤0.01% 4949
2024
Q3 		$0 Sell
23
-1
-4% -$10 ﹤0.01% 4881
2024
Q2 		$0 Hold
24
– – ﹤0.01% 4645
2024
Q1 		$0 Hold
24
– – ﹤0.01% 4386
2023
Q4 		$0 Hold
24
– – ﹤0.01% 4198
2023
Q3 		$0 Hold
24
– – ﹤0.01% 4232
2023
Q2 		$0 Hold
24
– – ﹤0.01% 4214
2023
Q1 		$0 Hold
24
– – ﹤0.01% 4096
2022
Q4 		$0 Sell
24
-23
-49% -$379 ﹤0.01% 4007
2022
Q3 		$1K Hold
47
– – ﹤0.01% 3623
2022
Q2 		$1K Buy
+47
New +$1.14K ﹤0.01% 3516
2022
Q1 		– Sell
-47
Closed -$2K – 3573
2021
Q4 		$2K Buy
+47
New +$2.98K ﹤0.01% 3103

Other funds holding HELP

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Carson Wealth (CWM LLC)'s HELP Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2025, closing a stake of 23 shares.

Carson Wealth (CWM LLC) first reported a position in HELP in Q4 2021 and held it in 15 quarters. The position peaked at $2K in Q4 2021. 80 funds tracked by Wall St. Rank hold HELP as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 23 Helus Pharma Inc. Common Stock shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and held it in 15 quarters.
  • Carson Wealth (CWM LLC)'s Helus Pharma Inc. Common Stock position peaked at $2K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.